We welcome Dr. Ken Ho, Infectious Disease Specialist at the University of Pittsburgh, to overview the COMPASS Study – Community Prevalence of SARS-CoV-2 Study. COMPASS will estimate the percentage of people affected by SARS-CoV-2, the virus that causes COVID-19. Pitt is one of 15 sites nationwide involved in the COMPASS study that will survey residents around the Pittsburgh area to learn who has antibodies against SARS-CoV-2 and who is carrying the virus at the time of the test.
Ho will detail how the study hopes to recruit 4,000 people: 500 from nursing homes and assisted living facilities, 500 from doctors’ offices and other outpatient facilities and 3,000 from the community. Recruitment will end in July or earlier if researchers meet their goal before then.
The overarching goal is to capture a cross-section of the community that represents our diverse populations and translates to data that will help us understand the epidemic better at the national and the local level.
